In two previous studies that compared human esophageal tissue samples, higher GPX2 expression and lower GPX3 expression were observed in BE patients than that in healthy controls [40] and the expression of GPX3 was lost in EA patients [39]. This evidence concerns the gene GPX2 and Barrett esophagus.